Developer docs
API playgroundTry for free, no card

Search company profiles

BIOMODEX

Full company profile

uuid0002z94

Namestring
BIOMODEX
Legal namestring
Biomodex
Websiteurl
biomodex.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

BIOMODEX is a Paris-headquartered medical technology company founded in 2015 by Thomas Marchand and Sidarth Radjou that develops patient-specific 3D-printed anatomical twins, marketed as biorealistic haptic simulators, for physician training and pre-operative rehearsal. The proprietary technology stack centers on INVIVOTECH (multi-material 3D printing that reproduces tissue-like biomechanical behavior from CT, MRI, or 3D rotational angiography inputs), ECHOTECH (ultrasound-compatible imaging properties for TEE and ICE), BLOODSIM (blood-analog fluid with matched viscosity and density), and THROMBOTECH (hydrogel synthetic clots), combined with Stratasys J750 Digital Anatomy 3D printers in Paris and Quincy, MA.

The product portfolio spans neurovascular (EVIAS Plus for unruptured aneurysm rehearsal and ischemic stroke mechanical thrombectomy, plus Aortic Arch Catheterism), cardiovascular (LAACS for left atrial appendage closure, Transseptal Puncture Training, Aortic System for TAVI/TAVR and valve-in-valve), and endovascular (EVAR for abdominal aortic aneurysm) applications, delivered as lightweight plug-and-play stations with a 5-day image-to-model turnaround. The company sells direct to hospitals and academic medical centers (Toronto Western, CHU Rennes, Fondation Adolphe de Rothschild, Beth Israel Lahey Health, Montreal Heart Institute) and to medical device manufacturers (Boston Scientific, Stryker, Corindus/Siemens Healthineers) for product validation, clinical studies, and physician training programs.

BIOMODEX generates revenue through hardware sales of simulation stations and disposable/reusable anatomical cartridges, supplemented by services tied to clinical studies and device launch support, with custom quotation-based enterprise pricing and multi-year contracts. Following Series A funding of $15M in June 2018 (total financing above $18.5M), the company established US operations, secured ISO 13485:2016 certification in 2020, and was ultimately acquired by Mentice AB in 2025, which acquired substantially all assets and integrated Biomodex into its endovascular simulation portfolio.

Short descriptiontext

BIOMODEX is a Paris-based medical technology company that develops 3D-printed patient-specific anatomical twins with haptic feedback for physician training and pre-operative rehearsal, serving hospitals, academic medical centers, and medical device manufacturers across neurovascular, cardiovascular, and endovascular procedures.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical simulation devices, 3D printed anatomical models, surgical rehearsal systems, haptic physician training, interventional procedure simulation
Industry4 codes
PRIMARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)
SECONDARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Simulation Devices
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
13D Printed Anatomical Models
TypeHardware Sales
Description

Sale of patient-specific 3D printed anatomical twin cartridges and simulation stations. Each printer can produce dozens of anatomical model cartridges per day.

biomodex.com
2Medical Device Validation Services
TypeProfessional Services
Description

Services to major medtech manufacturers including Boston Scientific and Stryker to validate new product lines and conduct clinical studies.

biomodex.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise/B2B pricing for hospitals and medical device manufacturers
ModelOtherBilling cadenceMulti-year contract
Notes

Direct B2B sales model. Major medtech manufacturers (Boston Scientific, Stryker) purchase models for product validation, clinical studies, and physician training.

biomodex.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1EVIAS™
Description

EndoVascular Intracranial Aneurysm System - patient-specific 3D printed models for neurovascular procedures

biomodex.com
+3 more records
Core offering1 text field

BIOMODEX manufactures and sells patient-specific 3D-printed anatomical twin simulators paired with portable plug-and-play stations for pre-procedural rehearsal and physician training across neurovascular, cardiovascular, and endovascular specialties. The offering combines proprietary INVIVOTECH biomechanical printing, ECHOTECH ultrasound-compatible imaging, and BLOODSIM blood-analog fluid dynamics to produce biorealistic haptic simulators used by hospitals, medical device manufacturers, and fellowship programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reliable reproduction of aneurysm features and parent vessel anatomy between 3D models and patient anatomy (per JNIS clinical study)
+3 more records
Product overview1 text field

BIOMODEX is a digital health company offering biorealistic haptic simulators for patient-specific rehearsal and physician training. The portfolio centers on two main simulation platforms: EVIAS Plus for neurovascular applications (including unruptured aneurysm and ischemic stroke training) and LAACS for cardiovascular applications (including left atrial appendage closure and transseptal puncture training). These are complemented by the Aortic System for valve procedures, EVAR System for abdominal aortic aneurysm, and Aortic Arch Catheterism modules. The systems combine 3D-printed patient-specific anatomical models with proprietary INVIVOTECH (biomechanical properties), ECHOTECH (ultrasound imaging compatibility), BLOODSIM (fluid dynamics), and Thrombotech (clot simulation) technologies, delivered through lightweight portable plug-and-play stations. The company operates from Paris and Boston, serving hospitals, medical device companies, and physicians across the U.S. and Europe.

Product and service6 records
1EVIAS Plus (EndoVascular Ischemic & Aneurysm System)
CategoryNeurovascular Surgical Simulation
Description

A neurovascular simulation system providing patient-specific 3D-printed anatomical models with haptic feedback for practicing intracranial aneurysm procedures and ischemic stroke treatment, including flow diversion, coil embolization, stent placement, and mechanical thrombectomy. Targeted at neurointerventionalists at hospitals and medical device manufacturers.

2LAACS (Left Atrial Appendage Closure System)
CategoryCardiovascular Surgical Simulation
Description

A cardiovascular training and rehearsal solution for left atrial appendage closure procedures, featuring TEE-compatible 3D-printed models with proprietary ECHOTECH and INVIVOTECH technologies for realistic imaging and haptic feedback. Used by interventional cardiologists and structural heart specialists at hospitals and medical device manufacturers.

3Aortic System
CategoryCardiovascular Surgical Simulation
Description

A cardiovascular simulation solution for aortic valve procedures including TAVI, TAVR, and valve-in-valve interventions, providing anatomical twins with femoral, transapical, and subclavian access points. Used to train interventional cardiologists and structural heart teams.

4Transseptal Puncture Training Solution
CategoryCardiovascular Surgical Simulation
Description

An echo-guided training system for transseptal puncture procedures using LAACS station compatibility, featuring ultrasound (TEE/ICE) compatible 3D-printed models with realistic haptic feedback and reusable frame with single-use septums. Targeted at electrophysiologists, interventional cardiologists, and fellowship programs.

5Aortic Arch Catheterism
CategoryNeurovascular Surgical Simulation
Description

A neurovascular training solution for aortic arch catheterization procedures, featuring multi-use Type I/II/III aortic arch cartridges compatible with the EVIAS Plus station, with right femoral and radial access options. Used by neurointerventionalists and trainees learning catheter access.

6EVAR System (EndoVascular Repair System)
CategoryEndovascular Surgical Simulation
Description

An endovascular training and rehearsal solution for unruptured abdominal aortic aneurysm procedures, providing anatomical twins with femoral access, physiological flow circulation, and contrast agent compatibility for EVAR, laser fenestration, and chimney procedures. Used by vascular surgeons and interventional radiologists.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2022-01-05
Description

Partnering to develop new cardiovascular training solution for pulsatile heart models to help cardiologists rehearse and train for complex valve-in-valve procedures.

Strategic tierSupportingTypeTechnology or IntegrationAnnounced on2021-12-08
Description

Partnership with Belfast medical imaging firm to speed up production of 3D-printed brain aneurysm models by cutting time to transform 2D medical images to 3D visuals.

Strategic tierStrategicTypeGTM or Marketing PartnerAnnounced on2021-09-17
Description

Collaboration to expand access to virtual medical education through live broadcasting of physician training and rehearsals. Enables live-streaming of Biomodex simulations for remote learner engagement.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic partnership using Stratasys J750 Digital Anatomy 3D Printers. Biomodex has two printers in Paris and one in Quincy facility. Long-standing relationship with plans to continue collaborating on new software and systems.

Strategic tierSupportingTypeTechnology or Integration
Description

Strategic supporter providing cloud access to design and simulation software and helping transition to cloud environment.

6Corindus (Siemens Healthineers)
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Collaboration for world's first in-human robotic-assisted neurovascular intervention. Biomodex EVIAS models used to rehearse robotic stent-assisted coiling procedures.

biomodex.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnerships with medical device manufacturers for validation of new product lines, conducting clinical studies, and physician training programs.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Public Swedish endovascular simulation company that acquired BIOMODEX's assets in 2025. Offers virtual reality-based interventional training and now combines its software simulators with BIOMODEX's physical anatomical twins, making it the most directly comparable and overlapping player in the endovascular simulation space.

TypeDirect peer
Description

Provides VR-based patient-specific surgical rehearsal and 360-degree visualization platforms for neurosurgery and other complex procedures. Competes with BIOMODEX in the patient-specific pre-operative rehearsal use case, but via virtual reality rather than 3D-printed physical models.

TypeDirect peer
Description

Offers haptic-enabled VR surgical training with multi-subject procedures including ophthalmology and orthopedics. Competes directly with BIOMODEX's EVIAS Plus and LAACS platforms by delivering realistic tactile feedback through software, providing a lower-cost, more scalable alternative to physical anatomical twins.

TypeBroad incumbent
Description

Division of CAE Inc. providing full-body manikin-based simulation and ultrasound/patient simulation training for medical education. Broad incumbent in healthcare simulation with established hospital sales channels and complementary procedural training products that partially overlap with BIOMODEX's training use case.

TypeBroad incumbent
Description

Acquired Simbionix to offer patient-specific surgical simulation and virtual reality training, alongside its core 3D printing business. Overlaps with BIOMODEX in both procedural simulation and 3D-printed anatomical models for surgical planning and training.

TypeDirect peer
Description

Belgian 3D printing services and software company with a dedicated medical division providing patient-specific surgical planning models, anatomical prints, and implants. Competes with BIOMODEX in patient-specific 3D-printed anatomical models for pre-operative planning across cardiovascular and orthopedic specialties.

TypeOthers
Description

BIOMODEX's primary 3D printing hardware partner supplying the J750 Digital Anatomy printers. A strategic enabling partner rather than direct competitor, but Stratasys's broader medical 3D printing roadmap and direct hospital relationships could create future competitive overlap.

TypeDirect peer
Description

Belfast-based medical 3D printing company and BIOMODEX partner focused on converting 2D medical imaging into 3D-printed anatomical models. Provides overlapping patient-specific anatomical model services to hospitals and competes for the same pre-operative planning use cases.

TypeEmerging player
Description

Provider of virtual dissection tables and 3D anatomy visualization products used in medical education and patient consultation. Competes in the broader anatomy visualization and medical training category with software-based alternatives to BIOMODEX's physical anatomical models.

10Osso VR
TypeEmerging player
Description

VR-based surgical training platform used by surgeons, medical device companies, and hospitals for procedure rehearsal and device training. Adjacent competitor targeting the same medical device manufacturer training budgets that BIOMODEX addresses with its EVIAS Plus and LAACS solutions.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIOMODEX

Medical Simulation Devicesbiomodex.com

BIOMODEX is a Paris-based medical technology company that develops 3D-printed patient-specific anatomical twins with haptic feedback for physician training and pre-operative rehearsal, serving hospitals, academic medical centers, and medical device manufacturers across neurovascular, cardiovascular, and endovascular procedures.

What BIOMODEX does

BIOMODEX is a Paris-headquartered medical technology company founded in 2015 by Thomas Marchand and Sidarth Radjou that develops patient-specific 3D-printed anatomical twins, marketed as biorealistic haptic simulators, for physician training and pre-operative rehearsal. The proprietary technology stack centers on INVIVOTECH (multi-material 3D printing that reproduces tissue-like biomechanical behavior from CT, MRI, or 3D rotational angiography inputs), ECHOTECH (ultrasound-compatible imaging properties for TEE and ICE), BLOODSIM (blood-analog fluid with matched viscosity and density), and THROMBOTECH (hydrogel synthetic clots), combined with Stratasys J750 Digital Anatomy 3D printers in Paris and Quincy, MA.

The product portfolio spans neurovascular (EVIAS Plus for unruptured aneurysm rehearsal and ischemic stroke mechanical thrombectomy, plus Aortic Arch Catheterism), cardiovascular (LAACS for left atrial appendage closure, Transseptal Puncture Training, Aortic System for TAVI/TAVR and valve-in-valve), and endovascular (EVAR for abdominal aortic aneurysm) applications, delivered as lightweight plug-and-play stations with a 5-day image-to-model turnaround. The company sells direct to hospitals and academic medical centers (Toronto Western, CHU Rennes, Fondation Adolphe de Rothschild, Beth Israel Lahey Health, Montreal Heart Institute) and to medical device manufacturers (Boston Scientific, Stryker, Corindus/Siemens Healthineers) for product validation, clinical studies, and physician training programs.

BIOMODEX generates revenue through hardware sales of simulation stations and disposable/reusable anatomical cartridges, supplemented by services tied to clinical studies and device launch support, with custom quotation-based enterprise pricing and multi-year contracts. Following Series A funding of $15M in June 2018 (total financing above $18.5M), the company established US operations, secured ISO 13485:2016 certification in 2020, and was ultimately acquired by Mentice AB in 2025, which acquired substantially all assets and integrated Biomodex into its endovascular simulation portfolio.

BIOMODEX firmographics

Firmographics
Name
BIOMODEX
Legal name
Biomodex
Website
https://biomodex.com
Company type
Private
Founded year
2015
Operating status
Acquired
Headcount range
51–100 employees
Short description
BIOMODEX is a Paris-based medical technology company that develops 3D-printed patient-specific anatomical twins with haptic feedback for physician training and pre-operative rehearsal, serving hospitals, academic medical centers, and medical device manufacturers across neurovascular, cardiovascular, and endovascular procedures.
Ownership category
akta.pro rank

BIOMODEX industry classification

Industry
Product category
Medical Simulation Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYEDAFAJAC
Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAAAFAI
Medical & Dental Prototyping (Models, Guides, Pre-Op Planning)
Industrials, Manufacturing & Construction/3D Printing/Rapid Prototyping & Product Development (Additive)
SECONDARYEDAFAJAJ
Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators)
Education/Education Technology (EdTech) & Digital Learning/AR/VR/XR, Simulations & Immersive Learning

Keywords

  • Medical simulation devices
  • 3D printed anatomical models
  • Surgical rehearsal systems
  • Haptic physician training
  • Interventional procedure simulation

Where BIOMODEX is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices3 records

Markets served

BIOMODEX business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. 3D Printed Anatomical Models: Sale of patient-specific 3D printed anatomical twin cartridges and simulation stations. Each printer can produce dozens of anatomical model cartridges per day.
  2. Medical Device Validation Services: Services to major medtech manufacturers including Boston Scientific and Stryker to validate new product lines and conduct clinical studies.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/B2B pricing for hospitals and medical device manufacturers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

BIOMODEX product offering

Product offering

Core offering

BIOMODEX manufactures and sells patient-specific 3D-printed anatomical twin simulators paired with portable plug-and-play stations for pre-procedural rehearsal and physician training across neurovascular, cardiovascular, and endovascular specialties. The offering combines proprietary INVIVOTECH biomechanical printing, ECHOTECH ultrasound-compatible imaging, and BLOODSIM blood-analog fluid dynamics to produce biorealistic haptic simulators used by hospitals, medical device manufacturers, and fellowship programs.

Product overview

BIOMODEX is a digital health company offering biorealistic haptic simulators for patient-specific rehearsal and physician training. The portfolio centers on two main simulation platforms: EVIAS Plus for neurovascular applications (including unruptured aneurysm and ischemic stroke training) and LAACS for cardiovascular applications (including left atrial appendage closure and transseptal puncture training). These are complemented by the Aortic System for valve procedures, EVAR System for abdominal aortic aneurysm, and Aortic Arch Catheterism modules. The systems combine 3D-printed patient-specific anatomical models with proprietary INVIVOTECH (biomechanical properties), ECHOTECH (ultrasound imaging compatibility), BLOODSIM (fluid dynamics), and Thrombotech (clot simulation) technologies, delivered through lightweight portable plug-and-play stations. The company operates from Paris and Boston, serving hospitals, medical device companies, and physicians across the U.S. and Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • EVIAS™: EndoVascular Intracranial Aneurysm System - patient-specific 3D printed models for neurovascular procedures
  • LAACS™
  • EVIAS Plus™
  • Transseptal Puncture Training

Products and services

  • EVIAS Plus (EndoVascular Ischemic & Aneurysm System) A neurovascular simulation system providing patient-specific 3D-printed anatomical models with haptic feedback for practicing intracranial aneurysm procedures and ischemic stroke treatment, including flow diversion, coil embolization, stent placement, and mechanical thrombectomy. Targeted at neurointerventionalists at hospitals and medical device manufacturers.
  • LAACS (Left Atrial Appendage Closure System) A cardiovascular training and rehearsal solution for left atrial appendage closure procedures, featuring TEE-compatible 3D-printed models with proprietary ECHOTECH and INVIVOTECH technologies for realistic imaging and haptic feedback. Used by interventional cardiologists and structural heart specialists at hospitals and medical device manufacturers.
  • Aortic System A cardiovascular simulation solution for aortic valve procedures including TAVI, TAVR, and valve-in-valve interventions, providing anatomical twins with femoral, transapical, and subclavian access points. Used to train interventional cardiologists and structural heart teams.
  • Transseptal Puncture Training Solution An echo-guided training system for transseptal puncture procedures using LAACS station compatibility, featuring ultrasound (TEE/ICE) compatible 3D-printed models with realistic haptic feedback and reusable frame with single-use septums. Targeted at electrophysiologists, interventional cardiologists, and fellowship programs.
  • Aortic Arch Catheterism A neurovascular training solution for aortic arch catheterization procedures, featuring multi-use Type I/II/III aortic arch cartridges compatible with the EVIAS Plus station, with right femoral and radial access options. Used by neurointerventionalists and trainees learning catheter access.
  • EVAR System (EndoVascular Repair System) An endovascular training and rehearsal solution for unruptured abdominal aortic aneurysm procedures, providing anatomical twins with femoral access, physiological flow circulation, and contrast agent compatibility for EVAR, laser fenestration, and chimney procedures. Used by vascular surgeons and interventional radiologists.

Quantifiable outcome

  • Reliable reproduction of aneurysm features and parent vessel anatomy between 3D models and patient anatomy (per JNIS clinical study)
  • +3 more outcomes

Companies that use BIOMODEX

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

BIOMODEX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

BIOMODEX partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered strategic, supporting and core.

  • Montreal Heart InstitutestrategicStrategic or Co-development Partner · 5 January 2022Partnering to develop new cardiovascular training solution for pulsatile heart models to help cardiologists rehearse and train for complex valve-in-valve procedures.
  • Axial3DsupportingTechnology or Integration · 8 December 2021Partnership with Belfast medical imaging firm to speed up production of 3D-printed brain aneurysm models by cutting time to transform 2D medical images to 3D visuals.
  • Avail MedsystemsstrategicGTM or Marketing Partner · 17 September 2021Collaboration to expand access to virtual medical education through live broadcasting of physician training and rehearsals. Enables live-streaming of Biomodex simulations for remote learner engagement.
  • StratasyscoreTechnology or IntegrationStrategic partnership using Stratasys J750 Digital Anatomy 3D Printers. Biomodex has two printers in Paris and one in Quincy facility. Long-standing relationship with plans to continue collaborating on new software and systems.
  • Dassault SystèmessupportingTechnology or IntegrationStrategic supporter providing cloud access to design and simulation software and helping transition to cloud environment.
  • Corindus (Siemens Healthineers)strategicStrategic or Co-development PartnerCollaboration for world's first in-human robotic-assisted neurovascular intervention. Biomodex EVIAS models used to rehearse robotic stent-assisted coiling procedures.
  • Medical Device ManufacturerscoreChannel Partner/ Reseller/ DistributorPartnerships with medical device manufacturers for validation of new product lines, conducting clinical studies, and physician training programs.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

BIOMODEX competitors and assessment

Company assessment

Broad incumbents

  • Mentice AB: Public Swedish endovascular simulation company that acquired BIOMODEX's assets in 2025. Offers virtual reality-based interventional training and now combines its software simulators with BIOMODEX's physical anatomical twins, making it the most directly comparable and overlapping player in the endovascular simulation space.
  • CAE Healthcare: Division of CAE Inc. providing full-body manikin-based simulation and ultrasound/patient simulation training for medical education. Broad incumbent in healthcare simulation with established hospital sales channels and complementary procedural training products that partially overlap with BIOMODEX's training use case.
  • 3D Systems (Simbionix): Acquired Simbionix to offer patient-specific surgical simulation and virtual reality training, alongside its core 3D printing business. Overlaps with BIOMODEX in both procedural simulation and 3D-printed anatomical models for surgical planning and training.

Direct peers

  • Surgical Theater: Provides VR-based patient-specific surgical rehearsal and 360-degree visualization platforms for neurosurgery and other complex procedures. Competes with BIOMODEX in the patient-specific pre-operative rehearsal use case, but via virtual reality rather than 3D-printed physical models.
  • FundamentalVR: Offers haptic-enabled VR surgical training with multi-subject procedures including ophthalmology and orthopedics. Competes directly with BIOMODEX's EVIAS Plus and LAACS platforms by delivering realistic tactile feedback through software, providing a lower-cost, more scalable alternative to physical anatomical twins.
  • Materialise: Belgian 3D printing services and software company with a dedicated medical division providing patient-specific surgical planning models, anatomical prints, and implants. Competes with BIOMODEX in patient-specific 3D-printed anatomical models for pre-operative planning across cardiovascular and orthopedic specialties.
  • Axial3D: Belfast-based medical 3D printing company and BIOMODEX partner focused on converting 2D medical imaging into 3D-printed anatomical models. Provides overlapping patient-specific anatomical model services to hospitals and competes for the same pre-operative planning use cases.

Others

  • Stratasys: BIOMODEX's primary 3D printing hardware partner supplying the J750 Digital Anatomy printers. A strategic enabling partner rather than direct competitor, but Stratasys's broader medical 3D printing roadmap and direct hospital relationships could create future competitive overlap.

Emerging players

  • Anatomage: Provider of virtual dissection tables and 3D anatomy visualization products used in medical education and patient consultation. Competes in the broader anatomy visualization and medical training category with software-based alternatives to BIOMODEX's physical anatomical models.
  • Osso VR: VR-based surgical training platform used by surgeons, medical device companies, and hospitals for procedure rehearsal and device training. Adjacent competitor targeting the same medical device manufacturer training budgets that BIOMODEX addresses with its EVIAS Plus and LAACS solutions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

BIOMODEX social profiles

Digital presence

BIOMODEX compliance and trust

Trust signal

Compliance1 record

BIOMODEX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIOMODEX leadership team

Management profile

Number of profiles

Profiles8 records

BIOMODEX subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

BIOMODEX funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIOMODEX M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOMODEX

What does BIOMODEX do?

BIOMODEX manufactures and sells patient-specific 3D-printed anatomical twin simulators paired with portable plug-and-play stations for pre-procedural rehearsal and physician training across neurovascular, cardiovascular, and endovascular specialties. The offering combines proprietary INVIVOTECH biomechanical printing, ECHOTECH ultrasound-compatible imaging, and BLOODSIM blood-analog fluid dynamics to produce biorealistic haptic simulators used by hospitals, medical device manufacturers, and fellowship programs.

Is BIOMODEX a public or private company?

BIOMODEX is a private company. It is classified as corporate owned and is currently acquired.

When was BIOMODEX founded?

BIOMODEX was founded in 2015. It employs 51 to 100 people.

Where is BIOMODEX based?

BIOMODEX is headquartered in Paris, France, in the Europe region.

How does BIOMODEX make money?

Two revenue lines are on record. 3D Printed Anatomical Models are the primary driver. The others are medical Device Validation Services.

Who are BIOMODEX's main competitors?

Broad incumbents on record are Mentice AB, CAE Healthcare and 3D Systems (Simbionix). Direct peers are Surgical Theater, FundamentalVR, Materialise and Axial3D. Stratasys is listed as an others. Emerging players are Anatomage and Osso VR.

Does BIOMODEX have an API?

No public API is recorded for BIOMODEX.

What industry is BIOMODEX in?

BIOMODEX's product category is Medical Simulation Devices. Its primary akta.pro industry code is EDAFAJAC, Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction), with a secondary code of IMAAADAG, Medical & Dental 3D Printing Services (patient-specific devices, dental labs). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
3dsBiomodexBiomodex, a Paris-based medical technology company founded by Thomas Marchand and Sidarth Radjou, uses advanced software and 3D printing to create life-like cardiovascular and neurovascular organ models for medical training and pre-operative preparation. The company addresses the problem of medical errors, which are estimated to cause hundreds of thousands of deaths annually, by enabling surgeons to practice procedures and medical students to gain experience without risking patients. Biomodex serves three main areas: education through anatomical models, pre-operative planning using patient-specific organ replicas from MRI/CT scans, and partnerships with medical device manufacturers.PR NewswireBiomodex® Announces Launch of Clear Cartridges for Neurovascular TrainingBiomodex announced the launch of Clear Cartridges, transparent 3D-printed anatomical models for physician training on ischemic stroke and unruptured aneurysm procedures without requiring a catheterization lab. The cartridges integrate with existing Biomodex EVIAS and EVIAS Plus stations and offer varying anatomical complexity for iterative training programs. Rapid Medical, a neurovascular medical device company, has already adopted the clear cartridges to train physicians on its new devices.GlobeNewswireBIOMODEX and Montreal Heart Institute Team Up to Develop 3D Printed Pulsatile Heart ModelsBiomodex and the Montreal Heart Institute announced a partnership to develop 3D-printed mitral and aortic valve models for training cardiologists on valve-in-valve procedures. The models will simulate patient-specific procedures with a specialized station and cardiac pump, aiming to reduce surgical errors and costs.PR NewswireBIOMODEX and Montreal Heart Institute Team Up to Develop 3D Printed Pulsatile Heart ModelsBIOMODEX, a Boston and Paris-based medical technology company specializing in biorealistic haptic simulators, has partnered with the Montreal Heart Institute to develop case-specific 3D-printed models of mitral and aortic valves that simulate a beating heart for physician training and rehearsal of complex cardiovascular procedures. The models will work with a specialized station and cardiac pump, allowing valves to open and close while enabling physicians to measure chamber pressure to ensure proper hemodynamics. The collaboration aims to reduce surgical and medical errors, procedural costs, and improve acute and chronic patient outcomes.PR NewswireBIOMODEX Launches Synthetic Clot Product for Neurovascular TrainingBiomodex launched Thrombotech, a hydrogel-based synthetic clot product for neurovascular training using its EVIAS Plus simulator. The product comes in three textures mimicking different clot compositions and is designed to improve training for thrombectomy procedures. It will be debuted at the 2021 Congress of Neurological Surgeons in Austin, TX.PR NewswireAvail Medsystems and Biomodex Join Forces to Expand Access to Virtual Medical EducationAvail Medsystems and Biomodex announced a collaboration on September 16, 2021, combining Avail's live-streaming video platform with Biomodex's 3D-printed biorealistic haptic simulators to expand virtual medical education capabilities for healthcare institutions. The partnership enables physician groups, health systems, and device companies to broadcast live rehearsals and training sessions, allowing medical professionals to observe and practice techniques in a risk-free virtual environment. This addresses growing demand for realistic, hands-on training opportunities amid time constraints facing busy physicians and medical device representatives.PR NewswireBIOMODEX Technology Enables New Milestone in Interventional CardiologyBIOMODEX announced that its LAACS (Left Atrial Appendage Closure System) simulation solution was used for the first time in North America to rehearse a full Left Atrial Appendage Occlusion procedure at the Montreal Heart Institute. Physicians used a 3D-printed patient-specific replica of the heart to practice with realistic catheter navigation, haptic feedback, and imaging before performing the actual procedure. Dr. Ibrahim and his team will present the live case at the TVT 2021 Structural Heart Summit in Miami.PR NewswireMedTech Veteran Rich Ferrari Joins BIOMODEX as First U.S. Board MemberBIOMODEX, a digital health company specializing in 3D printed patient-specific rehearsal and physician training solutions, has appointed MedTech veteran Rich Ferrari to its Board of Directors as its first U.S. board member. Ferrari brings 40 years of industry experience, having founded six companies and co-founded DeNovo Ventures, a Silicon Valley VC firm with $650 million under management dedicated to medical device investment. The appointment signals BIOMODEX's strategic focus on accelerating its presence in the U.S. market, where it already maintains operations alongside its Paris headquarters.PR NewswireBiomodex Teams Up with Physicians at Three of the World's Top Medical Centers to Develop a Cutting-Edge Training Solution for Treatment of Ischemic StrokeBiomodex partnered with three leading medical centers in France and the United States to develop EVIAS Plus, a 3D-printed training solution for ischemic stroke treatment. The system allows neurointerventionalists to simulate fluoroscopy-guided thrombectomy procedures using realistic models that replicate blood density and complex anatomies. This collaboration aims to accelerate physician training and address the shortage of specialists qualified to perform these emergency procedures.PR NewswireBIOMODEX Expands Product Offerings with Innovative Transseptal Puncture Training SolutionBIOMODEX, a digital health company headquartered in Paris and Boston, announced the launch of its Transseptal Puncture Training Solution, a next-generation training system designed for electrophysiologists and cardiologists to rehearse ultrasound-guided transseptal procedures. The system utilizes 3D-printed models with haptic feedback that simulate real heart tissue and blood vessels, incorporating the company's proprietary INVIVOTECH and ECHOTECH technologies for realistic tactile and ultrasound imaging properties. The training solution aims to address the rising demand for specialized training driven by increasing transseptal puncture procedures due to higher rates of atrial fibrillation and structural heart disease.